| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial
|
Lane, J Athene
|
|
2014
|
15 |
10 |
p. 1109-1118
10 p.
|
artikel
|
| 2 |
Adapted paediatric regimen benefits adults with ALL
|
Gilbert, Judith A
|
|
2014
|
15 |
10 |
p. e421-
1 p.
|
artikel
|
| 3 |
Blood-borne glioblastoma cells discovered
|
Burki, Talha Khan
|
|
2014
|
15 |
10 |
p. e422-
1 p.
|
artikel
|
| 4 |
Breast cancer: finding the silver lining in a dark cloud
|
Morgan, Jules
|
|
2014
|
15 |
10 |
p. 1064-
1 p.
|
artikel
|
| 5 |
Cancer survivors continue to smoke
|
Burki, Talha
|
|
2014
|
15 |
10 |
p. e423-
1 p.
|
artikel
|
| 6 |
Cetuximab or bevacizumab in metastatic colorectal cancer?
|
Sclafani, Francesco
|
|
2014
|
15 |
10 |
p. 1040-1041
2 p.
|
artikel
|
| 7 |
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
|
Stupp, Roger
|
|
2014
|
15 |
10 |
p. 1100-1108
9 p.
|
artikel
|
| 8 |
Cilengitide in glioblastoma: when did it fail?
|
Chinot, Olivier L
|
|
2014
|
15 |
10 |
p. 1044-1045
2 p.
|
artikel
|
| 9 |
Combination of stereotactic ablative body radiation with targeted therapies
|
Zeng, Jing
|
|
2014
|
15 |
10 |
p. e426-e434
nvt p.
|
artikel
|
| 10 |
Correction to Lancet Oncol 2014; 15: 933, 941
|
|
|
2014
|
15 |
10 |
p. e417-
1 p.
|
artikel
|
| 11 |
Correction to Lancet Oncol 2012; 13: 1261, 1263
|
|
|
2014
|
15 |
10 |
p. e417-
1 p.
|
artikel
|
| 12 |
Correction to Lancet Oncol 2014; 15: 957
|
|
|
2014
|
15 |
10 |
p. e417-
1 p.
|
artikel
|
| 13 |
Correction to Lancet Oncol 2014; 15: 966–74
|
|
|
2014
|
15 |
10 |
p. e417-
1 p.
|
artikel
|
| 14 |
Drug–drug interactions with tyrosine-kinase inhibitors
|
Croes, Sander
|
|
2014
|
15 |
10 |
p. e416-
1 p.
|
artikel
|
| 15 |
Dual targeting of HER2 with lapatinib and trastuzumab
|
Joensuu, Heikki
|
|
2014
|
15 |
10 |
p. 1050-1052
3 p.
|
artikel
|
| 16 |
Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial
|
Fizazi, Karim
|
|
2014
|
15 |
10 |
p. 1147-1156
10 p.
|
artikel
|
| 17 |
Electrotherapy: enlightening modern medicine
|
Hills, Allison
|
|
2014
|
15 |
10 |
p. 1060-1061
2 p.
|
artikel
|
| 18 |
EU regulation could harm cancer research
|
Burki, Talha Khan
|
|
2014
|
15 |
10 |
p. e421-
1 p.
|
artikel
|
| 19 |
Evidence-based care for trilateral retinoblastoma
|
Dimaras, Helen
|
|
2014
|
15 |
10 |
p. 1054-1055
2 p.
|
artikel
|
| 20 |
Fertility preservation for girls and young women with cancer: population-based validation of criteria for ovarian tissue cryopreservation
|
Wallace, W Hamish B
|
|
2014
|
15 |
10 |
p. 1129-1136
8 p.
|
artikel
|
| 21 |
Flexible sigmoidoscopy screening for colorectal cancer
|
Burki, Talha Khan
|
|
2014
|
15 |
10 |
p. e425-
1 p.
|
artikel
|
| 22 |
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial
|
Heinemann, Volker
|
|
2014
|
15 |
10 |
p. 1065-1075
11 p.
|
artikel
|
| 23 |
Friendship overcomes cancer
|
Gourd, Katherine
|
|
2014
|
15 |
10 |
p. 1063-
1 p.
|
artikel
|
| 24 |
Future of ALK inhibition in non-small-cell lung cancer
|
Reckamp, Karen L
|
|
2014
|
15 |
10 |
p. 1047-1049
3 p.
|
artikel
|
| 25 |
Global standards for paediatric oncology nursing in low-to-middle income countries
|
Liu, Fengxia
|
|
2014
|
15 |
10 |
p. e415-
1 p.
|
artikel
|
| 26 |
Guidance on the management of diarrhoea during cancer chemotherapy
|
Andreyev, Jervoise
|
|
2014
|
15 |
10 |
p. e447-e460
nvt p.
|
artikel
|
| 27 |
Ibrutinib: better combined with other drugs?
|
Ghia, Paolo
|
|
2014
|
15 |
10 |
p. 1043-1044
2 p.
|
artikel
|
| 28 |
Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer
|
Walker, Jane
|
|
2014
|
15 |
10 |
p. 1168-1176
9 p.
|
artikel
|
| 29 |
Lanreotide delays progression of neuroendocrine tumours
|
Gilbert, Judith A
|
|
2014
|
15 |
10 |
p. e418-
1 p.
|
artikel
|
| 30 |
Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response
|
de Azambuja, Evandro
|
|
2014
|
15 |
10 |
p. 1137-1146
10 p.
|
artikel
|
| 31 |
Life improving on art: paediatric cancer on film
|
Burki, Talha Khan
|
|
2014
|
15 |
10 |
p. 1064-
1 p.
|
artikel
|
| 32 |
Life's lessons, scantly observed
|
van Dorn, Aaron
|
|
2014
|
15 |
10 |
p. 1062-
1 p.
|
artikel
|
| 33 |
Lymphocytes prognostic in breast cancer
|
Sklan, Alexandra
|
|
2014
|
15 |
10 |
p. e422-
1 p.
|
artikel
|
| 34 |
MRD stratification for paediatric ALL
|
Mitchell, Chris
|
|
2014
|
15 |
10 |
p. e415-e416
nvt p.
|
artikel
|
| 35 |
Music against cancer
|
McLarnon, Andy
|
|
2014
|
15 |
10 |
p. 1061-1062
2 p.
|
artikel
|
| 36 |
New prostate cancer drugs: extending and improving life
|
Agarwal, Neeraj
|
|
2014
|
15 |
10 |
p. 1052-1054
3 p.
|
artikel
|
| 37 |
NICE guidance on enzalutamide for metastatic hormone-relapsed prostate cancer
|
Elsada, Ahmed
|
|
2014
|
15 |
10 |
p. 1058-1059
2 p.
|
artikel
|
| 38 |
NICE guidance on ipilimumab for treating previously untreated advanced (unresectable or metastatic) melanoma
|
Hall, Caroline J
|
|
2014
|
15 |
10 |
p. 1056-1057
2 p.
|
artikel
|
| 39 |
Osteosarcoma survivors' risk of second cancer
|
Bagcchi, Sanjeet
|
|
2014
|
15 |
10 |
p. e425-
1 p.
|
artikel
|
| 40 |
Ovarian tissue cryopreservation in children with cancer
|
Sarnacki, Sabine
|
|
2014
|
15 |
10 |
p. 1049-1050
2 p.
|
artikel
|
| 41 |
PALB2 gene increases breast cancer risk
|
Tanday, Sanjay
|
|
2014
|
15 |
10 |
p. e423-
1 p.
|
artikel
|
| 42 |
Pathogenesis, diagnosis, and treatment of composite lymphomas
|
Küppers, Ralf
|
|
2014
|
15 |
10 |
p. e435-e446
nvt p.
|
artikel
|
| 43 |
Patient priority in the era of patent expiries
|
The Lancet Oncology,
|
|
2014
|
15 |
10 |
p. 1039-
1 p.
|
artikel
|
| 44 |
Pembrolizumab for treatment of refractory melanoma
|
Bagcchi, Sanjeet
|
|
2014
|
15 |
10 |
p. e419-
1 p.
|
artikel
|
| 45 |
PSA testing beneficial for prostate cancer
|
Bagcchi, Sanjeet
|
|
2014
|
15 |
10 |
p. e424-
1 p.
|
artikel
|
| 46 |
Role of bisphosphonates in non-metastatic prostate cancer
|
Saad, Fred
|
|
2014
|
15 |
10 |
p. 1041-1042
2 p.
|
artikel
|
| 47 |
Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study
|
Gadgeel, Shirish M
|
|
2014
|
15 |
10 |
p. 1119-1128
10 p.
|
artikel
|
| 48 |
Safety and activity of ibrutinib plus rituximab for patients with high-risk chronic lymphocytic leukaemia: a single-arm, phase 2 study
|
Burger, Jan A
|
|
2014
|
15 |
10 |
p. 1090-1099
10 p.
|
artikel
|
| 49 |
Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial
|
Denham, James W
|
|
2014
|
15 |
10 |
p. 1076-1089
14 p.
|
artikel
|
| 50 |
Statins and breast cancer prognosis: evidence and opportunities
|
Ahern, Thomas P
|
|
2014
|
15 |
10 |
p. e461-e468
nvt p.
|
artikel
|
| 51 |
Sunitinib for atypical and anaplastic meningioma
|
Rahman, Ahmadur
|
|
2014
|
15 |
10 |
p. e424-
1 p.
|
artikel
|
| 52 |
Sunitinib still first-line therapy for metastatic renal cancer
|
Bagcchi, Sanjeet
|
|
2014
|
15 |
10 |
p. e420-
1 p.
|
artikel
|
| 53 |
Systemic anti-cancer therapy (SACT) dataset
|
Pickering, Lisa
|
|
2014
|
15 |
10 |
p. 1063-
1 p.
|
artikel
|
| 54 |
The ProtecT trial: what can we expect?
|
Roobol, Monique J
|
|
2014
|
15 |
10 |
p. 1046-1047
2 p.
|
artikel
|
| 55 |
Tobacco smoking declines in Australia
|
Burki, Talha Khan
|
|
2014
|
15 |
10 |
p. e418-
1 p.
|
artikel
|
| 56 |
Trilateral retinoblastoma: a systematic review and meta-analysis
|
de Jong, Marcus C
|
|
2014
|
15 |
10 |
p. 1157-1167
11 p.
|
artikel
|
| 57 |
Type 2 diabetes and risk of pancreatic adenocarcinoma
|
Rahman, Ahmadur
|
|
2014
|
15 |
10 |
p. e420-
1 p.
|
artikel
|
| 58 |
Variation in prostate cancer management
|
Burki, Talha Khan
|
|
2014
|
15 |
10 |
p. e419-
1 p.
|
artikel
|
Tijdschrift beschrijving